Cancer Research Horizons
Jonathan Tobin is currently a Partner at Brandon Capital where Jonathan focuses on leading investments in biotech companies globally. Jonathan also holds various Non-Executive Director positions in several pharmaceutical and biotech companies. In addition, Jonathan is a Member of the Investment Advisory Committee at KHAN Technology Transfer Fund I. Prior to their current roles, Jonathan served as the Managing Director at Arix Bioscience plc, specializing in biotech investments. Jonathan Tobin graduated with a MA in Biological Science from the University of Oxford, an MBA in Business Administration and Management from Imperial College London, and a PhD in Molecular Medicine from UCL.
This person is not in any teams
Cancer Research Horizons
Cancer Research Horizons is Cancer Research UK's innovation engine. We take scientific breakthroughs from the lab bench to the bedside, translating them into effective treatments and diagnostics for cancer patients. To date, we’ve played an instrumental role in forming over 60 spin-out companies and bringing 11 new cancer drugs to market, borne out of our pioneering research. We are the second biggest licensor of cancer research treatments globally and are part of Cancer Research UK – the world’s largest medical research charity. With exclusive rights to over £300m of world-class cancer research we’re a unique and powerful partner in the fight to beat cancer. We work closely with academia and industry to bridge the gap between research and the market, delivering maximum impact for patients. Every penny we make goes back into developing the next breakthroughs, helping bring forward the day when all cancer is conquered.